S&P affirms ratings on Medtronic (MDT); cuts outlook from Stable to Negative
S&P affirms ratings on Medtronic (NYSE: MDT); cuts outlook from Stable to Negative
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Medtronic (MDT) Raises Quarterly Dividend 13.2% to $0.43; 2% Yield
- Brexit Has No Immediate Impact On Republic of Ireland Sovereign Ratings - S&P
- U.K Vote Has No Immediate Effect on Domestic Banks - S&P
Create E-mail Alert Related CategoriesCredit Ratings
Related EntitiesStandard & Poor's
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!